Literature DB >> 17823850

Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers.

William F Anderson1, Bingshu E Chen, Louise A Brinton, Susan S Devesa.   

Abstract

BACKGROUND: Prior to 1999-2000, breast cancer incidence rates had risen for decades, though more among older than younger women.
MATERIALS AND METHODS: To further explore the impact of advancing age-at-diagnosis upon breast cancer incidence, we used the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program (1974-2003).
RESULTS: Over time, we observed age interactions by tumor grade, stage, and race. For example, among women ages <40 years, high-grade lesions were more common than low-grade tumors for all time periods. Among women ages 40+ years, high-grade lesions were more common during early time periods then trend lines crossed, after which low-grade tumors were more common than high-grade lesions. Notably, the transition (crossover point) occurred earlier with advancing age-at-diagnosis.
CONCLUSION: The reversal (crossing) of incidence rates from high to low-grade tumors among women 40+ years is a qualitative age interaction, probably due to changing age-related risk factor and/or screening patterns, where mammography preferentially detected tumors of low malignant potential among older women. Though once thought to be rare or artifactual, qualitative age interactions suggest breast cancer heterogeneity. Indeed, if real, qualitative age interactions (effect modifications) imply different etiologic pathways for early-onset and late-onset types of breast cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17823850     DOI: 10.1007/s10552-007-9057-x

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  24 in total

1.  Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.

Authors:  Tasha R Smith; Wen Liu-Mares; Beth O Van Emburgh; Edward A Levine; Glenn O Allen; Jeff W Hill; Isildinha M Reis; Laura A Kresty; Mark D Pegram; Mark S Miller; Jennifer J Hu
Journal:  Carcinogenesis       Date:  2011-06-23       Impact factor: 4.944

2.  Dermcidin expression is associated with disease progression and survival among breast cancer patients.

Authors:  Heather Ann Brauer; Monica D'Arcy; Tanya E Libby; Henry J Thompson; Yutaka Y Yasui; Nobuyuki Hamajima; Christopher I Li; Melissa A Troester; Paul D Lampe
Journal:  Breast Cancer Res Treat       Date:  2014-02-22       Impact factor: 4.872

3.  Hormone therapy and young-onset breast cancer.

Authors:  Katie M O'Brien; Chunyuan Fei; Dale P Sandler; Hazel B Nichols; Lisa A DeRoo; Clarice R Weinberg
Journal:  Am J Epidemiol       Date:  2015-02-18       Impact factor: 4.897

4.  Age-period-cohort models in cancer surveillance research: ready for prime time?

Authors:  Philip S Rosenberg; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

Review 5.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

6.  Risk factors and natural history of breast cancer in younger Chinese women.

Authors:  Winnie Yeo; Hang-Mei Lee; Amy Chan; Emily Yy Chan; Miranda Cm Chan; Keeng-Wai Chan; Sharon Ww Chan; Foon-Yiu Cheung; Polly Sy Cheung; Peter Hk Choi; Josette Sy Chor; William Wl Foo; Wing-Hong Kwan; Stephen Ck Law; Lawrence Pk Li; Janice Wh Tsang; Yuk Tung; Lorna Ls Wong; Ting-Ting Wong; Chun-Chung Yau; Tsz-Kok Yau; Benny Cy Zee
Journal:  World J Clin Oncol       Date:  2014-12-10

7.  Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.

Authors:  Briseis A Kilfoy; Susan S Devesa; Mary H Ward; Yawei Zhang; Philip S Rosenberg; Theodore R Holford; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

8.  Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium.

Authors:  Lynn Chollet-Hinton; Andrew F Olshan; Hazel B Nichols; Carey K Anders; Jennifer L Lund; Emma H Allott; Traci N Bethea; Chi-Chen Hong; Stephanie M Cohen; Thaer Khoury; Gary R Zirpoli; Virginia F Borges; Lynn A Rosenberg; Elisa V Bandera; Christine B Ambrosone; Julie R Palmer; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-09-13       Impact factor: 4.254

9.  Hairy cell leukaemia: a heterogeneous disease?

Authors:  Graça M Dores; Rayna K Matsuno; Dennis D Weisenburger; Philip S Rosenberg; William F Anderson
Journal:  Br J Haematol       Date:  2008-05-08       Impact factor: 6.998

10.  Recent changes in breast cancer incidence in Spain, 1980-2004.

Authors:  Marina Pollán; Roberto Pastor-Barriuso; Eva Ardanaz; Marcial Argüelles; Carmen Martos; Jaume Galcerán; María-José Sánchez-Pérez; María-Dolores Chirlaque; Nerea Larrañaga; Ruth Martínez-Cobo; María-Cres Tobalina; Enrique Vidal; Rafael Marcos-Gragera; Antonio Mateos; Isabel Garau; María-Dolores Rojas-Martín; Rosario Jiménez; Ana Torrella-Ramos; Josefina Perucha; Maria-Eugenia Pérez-de-Rada; Susana González; María-José Rabanaque; Joan Borràs; Carmen Navarro; Esther Hernández; Angel Izquierdo; Gonzalo López-Abente; Carmen Martínez
Journal:  J Natl Cancer Inst       Date:  2009-10-26       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.